ProCE Banner Activity

Immune Checkpoint Inhibitors for Early-Stage HCC and Advanced BTC

Slideset Download
Download this slideset for expert perspectives on emerging strategies in using immune checkpoint inhibitors for patients with early- and intermediate-stage hepatocellular carcinoma and advanced biliary tract cancers.

Released: June 17, 2021

Expiration: June 16, 2022

No longer available for credit.

Share

Faculty

Lipika Goyal

Lipika Goyal, MD, MPhil

Associate Professor in Medicine
Director of Gastrointestinal Oncology
Stanford School of Medicine
Palo Alto, California

Kate MacDougall

Kate MacDougall

Amit G. Singal

Amit G. Singal, MD, MS

Chief of Hepatology
Medical Director
, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Lipika Goyal, MD, MPhil

Associate Professor in Medicine
Director of Gastrointestinal Oncology
Stanford School of Medicine
Palo Alto, California

Kate MacDougall,

Amit G. Singal, MD, MS

Chief of Hepatology
Medical Director
, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas